Chronic marijuana use negatively impacts male reproductive health, may decrease testicular function

Oregon Health & Science University
OHSU study is the first to link daily use of edible THC with reduced testes size, lowered testosterone levels in nonhuman primates

Chronic use of marijuana may greatly impact male fertility and reproductive outcomes, says a new report published online in the journal Fertility & Sterility. The study is the first to assess the impacts of substance use on testicular function via a mode of delivery, and dosage, that reflects current human consumption.

Clinician-scientists at the Oregon National Primate Research Center at Oregon Health & Science University, monitored the reproductive systems of healthy male nonhuman primates following exposure to Delta-9-tetrahydrocannabinol, or THC — the main psychoactive ingredient in marijuana.

The nonhuman primates, all of reproductive age with a history of proven paternity and no prior exposure to cannabis, received a THC edible once daily over the course of seven months. Their THC dose was based on published medical marijuana acclimation recommendations for humans, and was increased every 70 days in alignment with the animals’ sperm development cycle. Dose adjustments were made until it reached the equivalent of a heavy medical marijuana dose in humans. Semen samples were collected at baseline before initiation of THC, and again at the end of each THC dosing timepoint.

Jamie Lo, M.D., M.C.R. (OHSU) A woman with long dark hair, smiling by the OHSU primate center.

Jamie Lo, M.D., M.C.R. (OHSU)

“Our analysis of the collected samples found that THC use was associated with significant adverse impacts to the animals’ reproductive hormones, including decreased levels of testosterone and severe testicular shrinkage. Specifically, we observed a greater than 50% decrease in testicular size,” said the study’s senior author Jamie Lo, M.D., M.C.R., associate professor of obstetrics and gynecology (perinatology and maternal-fetal medicine), OHSU School of Medicine, and Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center at OHSU. “Unfortunately, these effects appeared to worsen as the THC dose was increased, suggesting a possible dose-dependent effect.”

These results align with previous studies, conducted by Lo, that indicate similar THC-associated impacts to female reproductive hormones and the menstrual cycle.

Jason C. Hedges, M.D., Ph.D. (OHSU) A man with brown hair smiling.

Jason C. Hedges, M.D., Ph.D. (OHSU)

“While more research is necessary to better understand the potential long-term impacts of THC in humans, these early findings are concerning from a clinical standpoint,” said study lead author Jason C. Hedges, M.D., Ph.D., associate professor of urology in the OHSU School of Medicine. “As the prevalence of edible marijuana use continues to increase in the U.S. and worldwide — particularly in males of prime reproductive age — even moderate doses could have a profound impact on fertility outcomes. While family planning may not be top of mind for those in their late teens and early 20s, the longer-term effects of THC on male reproductive health are not well-defined; it is possible that THC could cause lasting impacts that may alter family planning later in life.”

In collaboration with Carol Hanna, Ph.D., director of the Assisted Reproductive Technology Core at Oregon National Primate Research Center at OHSU, and researchers from University of Georgia and Duke University, Lo and Hedges will continue to expand their understanding of the relationship between THC and reproductive health in both male and female nonhuman primates. The research team will examine longer term THC exposure impacts, including changes to sperm count and motility, and whether adverse effects may be reversed with the discontinuation of THC products.

This research is supported by National Institutes of Health grants awarded through the Reproductive Scientist Development Program (K12 HD000849), Eunice Kennedy Shriver National Institute of Child Health and Human Development (R03 HD097116), and the Office of Research Infrastructure Program (P51 OD011092); the National Institute of Drug Abuse; The Oregon Health & Science University Medical Research Foundation; and, a Faculty Excellence and Innovation Award given to Dr. Lo by the Silver Family Innovation Fund.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Institute of Drug Abuse.

This study was reviewed and approved by the OHSU Institutional Animal Care and Use Committee.

/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.